| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
MEETINGS
WANT TO PRESENT A POSTER?
There will be an opportunity to present posters on the broad subject area of the symposium, subject to acceptance of a submitted abstract.
Click here for details.
NOT A MEMBER? IT'S FREE...
If you are a member of the RSC or RPS, you join JPAG for free,
and benefit from discounted prices.
Click here for details.
REGISTER NOW...
Delegate fees include registration, documentation, lunch and refreshments.
DELEGATE RATES:
Concession : £ 45.00
Exhibitor SILVER : £ 850.00
Exhibitor-BRONZE : £ 700.00
Member : £ 195.00
Non-Member : £ 295.00
Student : £ 45.00
If you have any questions about the meeting, please contact us: events@jpag.org.
Please promote this event for us on your website or social media platform
SUBJECT: JPAG Symposium: Continuous Manufacturing and Analytical Strategy / Thursday 26th September 2024 / Royal Society of Chemistry, London
TITLE OF EVENT: Continuous Manufacturing and Analytical Strategy
DATE OF EVENT: Thursday 26th September 2024
EVENT LINK: https://www.jpag.org/173
VENUE: Royal Society of Chemistry, London
Burlington House, Piccadilly, London W1J 0BA
VENUE LINK: www.rsc.org/locations-contacts/
ORGANISED BY: Joint Pharmaceutical Analysis Group
WEB LINK: https://www.jpag.org/
SPONSORS: Royal Pharmaceutical Society and Royal Society of Chemistry
CONTACT: Hon Events Secretary JPAG, events@jpag.org
Continuous manufacturing offers great promise in improving productivity, efficiency and the intrinsic quality of both active pharmaceutical ingredients and formulated products.
Continuous manufacturing was defined by ICH Q13, the latest version of which completed consultation in 2021, was adopted by CHMP in December 2022 and officially came into effect in the EU in July 2023. The guidance is applicable to continuous manufacturing for new products and the conversion of batch to continuous manufacture for existing products. Changes to the definitions and processes around batch manufacture that carry through into analysis and release of the pharmaceutical product are described with concepts, scientific approaches, and regulatory considerations specific to continuous manufacture of drug substances and drug products.
This symposium will critically examine some of the challenges and opportunities that arise from adopting continuous manufacturing.
Leading regulators, industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of continuous manufacturing of drug substances and drug products.
The meeting is open to the submission of abstracts for oral presentations or posters in line with the above proposed key themes.
SPEAKERS:
Dr Ian Clegg - AstraZeneca
Dr Sean Clifford - AstraZeneca
Phil Doherty - Expo Process Analytics
John Mack - Applied Materials
Dr Deborah Mcelhone - Centre for Process Innovation
Dr Patrick Wray - Bristol-Myers Squibb
RETURN TO MEETINGS
Thursday 26th September 2024
Continuous Manufacturing and Analytical Strategy
Royal Society of Chemistry, London
Continuous manufacturing offers great promise in improving productivity, efficiency and the intrinsic quality of both active pharmaceutical ingredients and formulated products.
Continuous manufacturing was defined by ICH Q13, the latest version of which completed consultation in 2021, was adopted by CHMP in December 2022 and officially came into effect in the EU in July 2023. The guidance is applicable to continuous manufacturing for new products and the conversion of batch to continuous manufacture for existing products. Changes to the definitions and processes around batch manufacture that carry through into analysis and release of the pharmaceutical product are described with concepts, scientific approaches, and regulatory considerations specific to continuous manufacture of drug substances and drug products.
This symposium will critically examine some of the challenges and opportunities that arise from adopting continuous manufacturing.
Leading regulators, industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of continuous manufacturing of drug substances and drug products.
The meeting is open to the submission of abstracts for oral presentations or posters in line with the above proposed key themes.
Continuous Manufacturing and Analytical Strategy
Royal Society of Chemistry, London
Continuous manufacturing offers great promise in improving productivity, efficiency and the intrinsic quality of both active pharmaceutical ingredients and formulated products.
Continuous manufacturing was defined by ICH Q13, the latest version of which completed consultation in 2021, was adopted by CHMP in December 2022 and officially came into effect in the EU in July 2023. The guidance is applicable to continuous manufacturing for new products and the conversion of batch to continuous manufacture for existing products. Changes to the definitions and processes around batch manufacture that carry through into analysis and release of the pharmaceutical product are described with concepts, scientific approaches, and regulatory considerations specific to continuous manufacture of drug substances and drug products.
This symposium will critically examine some of the challenges and opportunities that arise from adopting continuous manufacturing.
Leading regulators, industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of continuous manufacturing of drug substances and drug products.
The meeting is open to the submission of abstracts for oral presentations or posters in line with the above proposed key themes.
WANT TO PRESENT A POSTER?
There will be an opportunity to present posters on the broad subject area of the symposium, subject to acceptance of a submitted abstract.
Click here for details.
NOT A MEMBER? IT'S FREE...
If you are a member of the RSC or RPS, you join JPAG for free,
and benefit from discounted prices.
Click here for details.
REGISTER NOW...
Delegate fees include registration, documentation, lunch and refreshments.
DELEGATE RATES:
Concession : £ 45.00
Exhibitor SILVER : £ 850.00
Exhibitor-BRONZE : £ 700.00
Member : £ 195.00
Non-Member : £ 295.00
Student : £ 45.00
If you have any questions about the meeting, please contact us: events@jpag.org.
 | Add the meeting to your calendar by clicking on this icon. (if it first downloads, you will need to double-click the download) |
 | Why not share this meeting with your friends? Send link: https://www.jpag.org/173   |
Please promote this event for us on your website or social media platform
SUBJECT: JPAG Symposium: Continuous Manufacturing and Analytical Strategy / Thursday 26th September 2024 / Royal Society of Chemistry, London
TITLE OF EVENT: Continuous Manufacturing and Analytical Strategy
DATE OF EVENT: Thursday 26th September 2024
EVENT LINK: https://www.jpag.org/173
VENUE: Royal Society of Chemistry, London
Burlington House, Piccadilly, London W1J 0BA
VENUE LINK: www.rsc.org/locations-contacts/
ORGANISED BY: Joint Pharmaceutical Analysis Group
WEB LINK: https://www.jpag.org/
SPONSORS: Royal Pharmaceutical Society and Royal Society of Chemistry
CONTACT: Hon Events Secretary JPAG, events@jpag.org
Continuous manufacturing offers great promise in improving productivity, efficiency and the intrinsic quality of both active pharmaceutical ingredients and formulated products.
Continuous manufacturing was defined by ICH Q13, the latest version of which completed consultation in 2021, was adopted by CHMP in December 2022 and officially came into effect in the EU in July 2023. The guidance is applicable to continuous manufacturing for new products and the conversion of batch to continuous manufacture for existing products. Changes to the definitions and processes around batch manufacture that carry through into analysis and release of the pharmaceutical product are described with concepts, scientific approaches, and regulatory considerations specific to continuous manufacture of drug substances and drug products.
This symposium will critically examine some of the challenges and opportunities that arise from adopting continuous manufacturing.
Leading regulators, industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of continuous manufacturing of drug substances and drug products.
The meeting is open to the submission of abstracts for oral presentations or posters in line with the above proposed key themes.
SPEAKERS:
Dr Ian Clegg - AstraZeneca
Dr Sean Clifford - AstraZeneca
Phil Doherty - Expo Process Analytics
John Mack - Applied Materials
Dr Deborah Mcelhone - Centre for Process Innovation
Dr Patrick Wray - Bristol-Myers Squibb
RETURN TO MEETINGS
INTERESTED IN THIS EVENT?
We will keep you informed...
We will keep you informed...
All JPAG-hosted meetings award 4 hours of CPD points.
INVOICES & RECEIPTS are available: Please see the e-mail you receive after registration.
LOOKING FOR YOUR EVENT TICKET? Please see the e-mail you receive after registration.
VENUE INFORMATION
PRESENTING A POSTER?
INVOICES & RECEIPTS are available: Please see the e-mail you receive after registration.
LOOKING FOR YOUR EVENT TICKET? Please see the e-mail you receive after registration.
VENUE INFORMATION
PRESENTING A POSTER?
We always seek feedback from delegates attending JPAG events through an Evaluation form.
A recent analysis of the results has shown that more than 95% of attendees thought that JPAG meetings were well planned, relevant and met their main objectives, and would recommend JPAG meetings to colleagues
TESTIMONIALS...
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
I did appreciate receiving the slides before, as then I could print them and make notes around them during the symposium.
Getting an industry perspective on this topic was most helpful.
I appreciate having access to relevant JPAG seminars from overseas; provision of lectures beforehand to allow reading beforehand.
I did like having the presentations available early, with the webinar portion being focused on Q&A.
Fantastic to hear from NHS speaker, provides real insight to patient/clinician considerations that we don't necessarily see in industry.
From attendee perspective, the course did not take up the whole day as no travel necessary and overall good value for money.
Hearing the information from the clinical setting side was very useful.
Well organized. This was an amazing session. Prior sharing of the presentation was a great add on!
The most useful aspect of the webinar was the variety in the presentations across industry and the regulators. Really good to review the presentations beforehand.
Good value, well organised symposium. Always useful for focused topics.
A very good day. Enjoyed getting to speak to the presenters to discuss current challenges in industry.
Well done to all the speakers and the organisers for being able to successfully hold highly informative conferences virtually! (July 2020)
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
I did appreciate receiving the slides before, as then I could print them and make notes around them during the symposium.
Getting an industry perspective on this topic was most helpful.
I appreciate having access to relevant JPAG seminars from overseas; provision of lectures beforehand to allow reading beforehand.
I did like having the presentations available early, with the webinar portion being focused on Q&A.
Fantastic to hear from NHS speaker, provides real insight to patient/clinician considerations that we don't necessarily see in industry.
From attendee perspective, the course did not take up the whole day as no travel necessary and overall good value for money.
Hearing the information from the clinical setting side was very useful.
Well organized. This was an amazing session. Prior sharing of the presentation was a great add on!
The most useful aspect of the webinar was the variety in the presentations across industry and the regulators. Really good to review the presentations beforehand.
Good value, well organised symposium. Always useful for focused topics.
A very good day. Enjoyed getting to speak to the presenters to discuss current challenges in industry.
Well done to all the speakers and the organisers for being able to successfully hold highly informative conferences virtually! (July 2020)
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
PAST MEETINGS
Delegates at a symposium held at the Royal Society of Chemistry
| Call us: | CONTACT US | Follow us: |     | Terms and Conditions Privacy Statement |
| Joint Pharmaceutical Analysis Group 2024 Website © and by Delta Consultancy Services |
|